1. Home
  2. ZLAB vs BLKB Comparison

ZLAB vs BLKB Comparison

Compare ZLAB & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • BLKB
  • Stock Information
  • Founded
  • ZLAB 2013
  • BLKB 1981
  • Country
  • ZLAB China
  • BLKB United States
  • Employees
  • ZLAB N/A
  • BLKB N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • BLKB Computer Software: Prepackaged Software
  • Sector
  • ZLAB Health Care
  • BLKB Technology
  • Exchange
  • ZLAB Nasdaq
  • BLKB Nasdaq
  • Market Cap
  • ZLAB 4.0B
  • BLKB 3.2B
  • IPO Year
  • ZLAB 2017
  • BLKB 2004
  • Fundamental
  • Price
  • ZLAB $33.34
  • BLKB $65.79
  • Analyst Decision
  • ZLAB Buy
  • BLKB Hold
  • Analyst Count
  • ZLAB 6
  • BLKB 3
  • Target Price
  • ZLAB $57.22
  • BLKB $78.67
  • AVG Volume (30 Days)
  • ZLAB 537.8K
  • BLKB 317.8K
  • Earning Date
  • ZLAB 08-07-2025
  • BLKB 10-29-2025
  • Dividend Yield
  • ZLAB N/A
  • BLKB N/A
  • EPS Growth
  • ZLAB N/A
  • BLKB N/A
  • EPS
  • ZLAB N/A
  • BLKB N/A
  • Revenue
  • ZLAB $427,799,000.00
  • BLKB $1,141,002,000.00
  • Revenue This Year
  • ZLAB $42.62
  • BLKB N/A
  • Revenue Next Year
  • ZLAB $55.12
  • BLKB $4.18
  • P/E Ratio
  • ZLAB N/A
  • BLKB N/A
  • Revenue Growth
  • ZLAB 32.56
  • BLKB 0.16
  • 52 Week Low
  • ZLAB $18.91
  • BLKB $58.05
  • 52 Week High
  • ZLAB $44.34
  • BLKB $88.95
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 43.89
  • BLKB 53.40
  • Support Level
  • ZLAB $31.79
  • BLKB $64.89
  • Resistance Level
  • ZLAB $35.45
  • BLKB $66.92
  • Average True Range (ATR)
  • ZLAB 1.00
  • BLKB 1.44
  • MACD
  • ZLAB -0.22
  • BLKB 0.24
  • Stochastic Oscillator
  • ZLAB 31.12
  • BLKB 67.85

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About BLKB Blackbaud Inc.

Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.

Share on Social Networks: